abstract |
The present invention relates to compounds of the general formula (I) in which the meanings of the substituents R1, R2, Ar and X are as described in the specification, and physiologically acceptable salts thereof. The invention also relates to a process for the preparation of the compounds and their use as medicaments. The compounds of the present invention are poly (ADP-ribose) polymerase (PARP) inhibitors. [Chemical 1] |